Chinese Biotech Firm LianBio Prices US$325 Million Nasdaq IPO

Biotech company LianBio (Nasdaq: LIAN) started trading on the Nasdaq Global Market today. The Shanghai-based firm aims to raise approximately US$325 million in its debut on the US big board.

The offering consisted of 20,312,500 American depositary shares at US$16.00 per ADS, which represents 1 ordinary company share. The ADSs will be trading on the Nasdaq exchange under the symbol “LIAN”.

Goldman Sachs & Co., Jefferies, and BofA Securities, Inc. are acting as the joint bookrunners for the said offering. The underwriters were given a 30-day over-allotment option to purchase up to an additional 3,046,875 ADSs at the same IPO price.

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

The company also has its offices in Princeton, New Jersey. According to its website, the firm aims “to bring transformative medicines to historically underserved patients in China and other Asian markets.”


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Questcorp Begins 600 Metre Phase 2B Drill Program at La Union

Selkirk Copper Wraps 54,579 Metre Phase 2 Program at Minto, Hits 5.97% Copper Equivalent

Related News

Morningstar Sees SpaceX Worth Half Its IPO Price

Morningstar thinks SpaceX is worth roughly half of what the rocket and satellite company is...

Monday, June 8, 2026, 12:26:23 PM

Trump Brothers Give Blank-Check Another Try In A $300M SPAC IPO

New America Acquisition I Corp. promises to “revitalize domestic manufacturing,” yet its biggest beneficiaries at...

Tuesday, August 5, 2025, 08:05:00 AM

Cannabis SPAC Clover Leaf Capital Prices US$125 Million IPO

Special purpose acquisition company Clover Leaf Capital Corp. started trading its securities on the Nasdaq...

Tuesday, July 20, 2021, 04:46:00 PM

Former Apollo Global Exec-Led SPAC Beard Energy Transition Acquisition Prices US$200 Million IPO

Blank check company Beard Energy Transition Acquisition Corp. (NYSE: BRDU) went public yesterday on the...

Thursday, November 25, 2021, 02:08:00 PM

ESG SPAC GSR II Meteora Acquisition Prices Upsized US$275 Million IPO

Special purpose acquisition company GSR II Meteora Acquisition Corp (Nasdaq: GSRMU) started trading publicly on...

Friday, February 25, 2022, 03:04:00 PM